Role of the amygdala and periaqueductal gray in anxiety and panic

Behavioural Brain Research - Tập 58 - Trang 123-131 - 1993
Frederico G. Graeff1, Maria Cristina L. Silveira1, Regina L. Nogueira1, Elisabeth A. Audi2, Rúbia Maria W. Oliveira2
1Laboratory of Psychobiology, FFCLRP and Center for Neuroscience and Behavior of the University of São Paulo, Campus of Ribeirão Preto, SP 14040-901 Brazil
2Department of Pharmacy and Pharmacology, CCBS, State University of Maringá, Maringá Brazil

Tài liệu tham khảo

Audi, 1984, Benzodiazepine receptors in the periaqueductal grey mediate anti-aversive drug action, Eur. J. Pharmacol., 103, 279, 10.1016/0014-2999(84)90488-6 Audi, 1987, GABA-A receptors in the midbrain central grey mediate the antiaversive action of GABA, Eur. J. Pharmacol., 135, 225, 10.1016/0014-2999(87)90615-7 Audi, 1988, Mediation by serotonin of the antiaversive effect of zimelidine and propranolol injected into the dorsal midbrain central grey, J. Psycopharmacol., 2, 26, 10.1177/026988118800200105 Audi, 1991, Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin, Psychopharmacology, 105, 553, 10.1007/BF02244379 Azmitia, 1978, The serotonin-producing neurons of the midbrain median and dorsal raphe nuclei, 233 Ballenger, 1990, Efficacy of benzodiazepines in panic disorder and agoraphobia, J. Psychiatry, 24, 15 Beckett, 1992, Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray, Psychopharmacology, 108, 110, 10.1007/BF02245294 Bolles, 1980, A perceptual defensive-recuperative model of fear and pain, Behav. Brain Res., 3, 291, 10.1017/S0140525X0000491X Brandão, 1991, Electrophysiological evidence for excitatory 5-HT2 and depressant 5-HT1A receptors on neurones of the rat midbrain tectum, Brain Res., 556, 259, 10.1016/0006-8993(91)90313-K Bullitt, 1990, Expression of c-fos protein as a marker for neuronal activity following noxious stimulation in the rat, J. Comp. Neurol., 296, 517, 10.1002/cne.902960402 Celeumans, 1985, The influence of ritanserin, a serotonin antagonist in anxiety disorders: a double-blind placebo-controlled study versus lorazepam, Pharmacopsychiatry, 18, 303, 10.1055/s-2007-1017385 Clarke, 1982, Effects of ACTH, benzodiazepines and 5-HT antagonists on escape from periaqueductal grey stimulation in the rat, Prog. Neuro Psychopharmacol. Biol. Psychiatry, 6, 27, 10.1016/S0364-7722(82)80104-5 Deakin, 1991, 5-HT and mechanisms of defence, J. Psychopharmacol., 5, 305, 10.1177/026988119100500414 Den Boer, 1990, Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin, Psychopharmacology, 102, 85, 10.1007/BF02245749 Dragunow, 1989, The use of c-fos as a metabolic marker in neuronal pathway tracing, J. Neurosci. Methods, 29, 261, 10.1016/0165-0270(89)90150-7 Engel, 1986, Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) auto-receptors in the rat brain cortex with 5-HT1B binding sites, Naunyn Schmiedeberg's Arch. Pharmacol., 332, 1, 10.1007/BF00633189 Fanselow, 1991, The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety, 151 Gastfriend, 1989, Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder, Am. J. Psychiatry, 146, 914, 10.1176/ajp.146.7.914 Graeff, 1987, Antiaversive action of drugs, Vol. 6, 129 Graeff, 1990, Brain defense systems and anxiety, 307 Graeff, 1991, Neurotransmitters in the dorsal periaqueductal gray and animal models of panic anxiety, 288 Guimarães, 1991, Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey, Psychopharmacology, 103, 91, 10.1007/BF02244080 Guimarães, F.S., Mbaya, P.S. and Deakin, J.F.W., Ritanserin facilitates anxiety in a simulated public speaking paradigm, Psychoparmacology, submitted. Handley, 1984, Effects of alpha-adrenoceptor agonists in a maze-exploration model of “fear”-motivated behaviour, Naunyn-Schmiedeberg's Arch. Pharmacol., 327, 1, 10.1007/BF00504983 Hensman, 1991, The effects of ritanserin on aversive classical conditioning in humans, Psychopharmacology, 104, 220, 10.1007/BF02244182 Hodges, 1987, Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not in discrimination, Psychopharmacology, 92, 491, 10.1007/BF00176484 Hoyer, 1991, The 5-HT receptor family: ligands, distribution and receptor-effector coupling, 31 Jacobs, 1991, Activity of brain serotonergic neurons in the behaving animal, Pharmacol. Rev., 43, 563 Jenck, 1989, Effects of serotonin receptor antagonists on PAG stimulation induced aversion: different contributions of 5-HT1, 5-HT2 and 5-HT3 receptors, Psychopharmacology, 97, 489, 10.1007/BF00439553 Jenck, 1989, Opposite control mediated by central 5HT1A and non-5HT1A (5HT1B or 5H1C) receptors on periaqueductal gray aversion, Eur. J. Pharmacol., 161, 219, 10.1016/0014-2999(89)90847-9 Jenck, 1990, 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats, Psychopharmacology, 100, 372, 10.1007/BF02244609 Jenck, 1990, The effect of antidepressants on aversive PAG stimulation, Eur. J. Pharmacol., 177, 201, 10.1016/0014-2999(90)90271-7 Kalén, 1989, Hippocampal noradrenaline and serotonin release over 24 hours as measured by the dialysis technique in freely moving rats: correlation to behavioural activity state, effect of handling and tail pinch, Eur. J. Neurosci., 1, 181, 10.1111/j.1460-9568.1989.tb00786.x Kiser, 1975, Monoaminergic mechanisms in aversive brain stimulation, Physiol. Behav., 15, 47, 10.1016/0031-9384(75)90278-4 Kiser, 1978, Anatomic and pharmacologic differences between two types of aversive midbrain stimulation, Brain Res., 155, 331, 10.1016/0006-8993(78)91026-0 Mammounas, 1991, Dual serotonergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives, J. Comp. Neurol., 314, 558, 10.1002/cne.903140312 Middlemiss, 1984, Stereoselective blockade at [3H] 5-HT binding sites and at the 5-HT autoreceptor by propranolol, Eur. J. Pharmacol., 101, 289, 10.1016/0014-2999(84)90173-0 Nashold, 1974, The midbrain and pain, 191 Nogueira, 1991, 5-HT mediation of the antiaversive effect of isamoltane injected into the dorsal periaqueductal grey, Behav. Pharmacol., 2, 73, 10.1097/00008877-199102000-00010 Olds, 1962, Approach-escape interactions in rat brain, Am. J. Physiol., 203, 803, 10.1152/ajplegacy.1962.203.5.803 Paxinos, 1986 Pellow, 1986, Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat, Pharmacol. Biochem. Behav., 24, 525, 10.1016/0091-3057(86)90552-6 Pellow, 1985, Validation of open:closed arm entries in the elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Meth., 14, 149, 10.1016/0165-0270(85)90031-7 Petersen, 1984, Anticonflict effects of 5-HT antagonists by intraamygdaloid injection, 654 Petersen, 1985, Evidence that the anticonflict effect of midazolam in the amygdala is mediated by specific benzodiazepine receptors, Neurosci. Lett., 53, 285, 10.1016/0304-3940(85)90552-X Puttkammer, 1987, Zur anxiolytishen Wirkung eines Phenoxypropanolamin-Derivates im Vergleich zu Propranolol, Diazepam und Plazebo, Drug Res., 37, 721 Russo, 1993, Role of benzodiazepine receptors located in the dorsal periaqueductal grey in anxiety, Psychopharmacology, 106, 198, 10.1007/BF02246973 Scheel-Krüger, 1982, Anticonflict effect of benzodiazepines mediated by a GABA-ergic mechanism in the amygdala, Eur. J. Pharmacol., 82, 115, 10.1016/0014-2999(82)90564-7 Schenberg, 1978, Role of the periqueductal gray substance in the antianxiety action of benzodiazepines, Pharmacol. Biochem. Behav., 9, 287, 10.1016/0091-3057(78)90287-3 Schmitt, 1986, A neuropharmacological study of the periventricular neural substrate involved in flight, Behav. Brain Res., 22, 181, 10.1016/0166-4328(86)90039-2 Schütz, 1985, Anti-aversive role of serotonin on the dorsal periaqueductal grey matter, Psychopharmacology, 85, 340, 10.1007/BF00428199 Scott Young, 1980, Radiohistochemical localization of benzodiazepine receptors in the rat brain, J. Pharmacol. Exp. Ther., 212, 337 Sheehan, 1988, The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report, Pharmacol. Biochem. Behav., 29, 815, 10.1016/0091-3057(88)90214-6 Sheldon, 1990, Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: evidence for the involvement of a 5-HT2-activated interneuron, Brain Res., 506, 62, 10.1016/0006-8993(90)91199-Q Singh, 1990, The increases in rat cortical and midbrain tryptophan hydroxylase activity in response to acute or repeated sound stress are blocked by bilateral lesions to the central nucleus of the amygdala, Brain Res., 530, 49, 10.1016/0006-8993(90)90656-V Stein, 1973, Antianxiety action of benzodiazepines: decrease in activity of serotonin neurons in the punishment system, 299 Walletschek, 1981, Spontaneous activity of dorsal raphe neurons during defensive and offensive encounters in the tree-shrew, Physiol. Behav., 28, 697, 10.1016/0031-9384(82)90054-3 Zuardi, 1993, Effects of ipsapirone and cannabidiol on human experimental anxiety, J. Psychopharmacol., 7, 82, 10.1177/026988119300700112